secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0000950170-23-069051
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus receives Nasdaq deficiency notice for bid price below $1.00; has 180 days to cure
--------------------------------------------------------------------------------

- On Dec 4, 2023, Nasdaq notified Agenus that its common stock's closing bid price was below $1.00 for 31 consecutive business days.
- Company has until June 3, 2024 to regain compliance by maintaining a $1.00+ closing bid price for 10 consecutive business days.
- If not cured by June 3, Agenus may be eligible for an additional 180-day extension subject to meeting other listing standards.
- Company is confident in resolving the deficiency; reverse stock split is under consideration but not the primary focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000095017023069051/0000950170-23-069051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000095017023069051/agen-20231204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-069051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer